Anti-Pan Actin (2A3)- Biotin
Anti-Pan Actin (2A3)- Biotin
Product No.: A471
- -
- -
Clone 2A3 Target Pan Actin Formats AvailableView All Product Type Hybridoma Monoclonal Antibody
Alternate Names Skeletal muscle alpha actin, Smooth muscle alpha actin, Cytoplasmic beta actin, Cardiac muscle alpha actin, Cytoplasmic gamma actin, Smooth muscle gamma actin Isotype Mouse IgG1 κ Applications IF , IHC , IP , WB |
- -
- -
Antibody DetailsProduct DetailsReactive Species Drosophila ⋅ Hamster ⋅ Human ⋅ Monkey ⋅ Mouse ⋅ Rat Host Species Mouse Immunogen KLH-coupled peptide fragment corresponding to the C-terminal region of β-Actin of human origin Product Concentration 0.5 mg/ml Formulation This Biotinylated antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative. State of Matter Liquid Storage and Handling This biotinylated antibody is stable when stored at 2-8°C. Do not freeze. Regulatory Status Research Use Only Country of Origin USA Shipping 2 – 8° C Wet Ice Additional Applications Reported In Literature ? WB, IHC, IF, IP Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity 2A3 activity is directed against all actin isoforms in a variety of species. Background Actin is the most abundant protein in most eukaryotic cells and in vertebrates is expressed in three main isoforms: alpha, beta, and gamma 1. The alpha isoform is expressed as three different variants in skeletal, cardiac, and smooth muscles, while the beta and gamma isoforms are expressed in non-muscle and muscle cells. In particular, beta-actin is found at the extended edge of cells in two modes: globular and fibrous 2. Actin isoforms are highly conserved, differing in only a few amino acids, often in the N terminus 1. Actin is essential for the survival of most cells 3. It polymerizes into filaments that provide internal mechanical support as part of the cytoskeleton, acts as tracks responsible for the movement of intracellular materials such as organelles or secretory vesicles, and can create forces necessary to drive cell movement. Actin polymerization can also contribute to endocytosis. Beta-actin is a housekeeping gene with relatively stable expression in most cells and is often used in experiments as an internal reference of total protein 2 . However, beta-actin expression becomes unstable in a variety of pathological settings including cerebrovascular disease 2 (subarachnoid hemorrhage and stroke), cancer 4, and in some disease models 2 and is being investigated as a possible biomarker in some contexts 2. Monoclonal antibody 2A3 (aka 2A3-6A5-G2) was raised in mouse against a KLH-peptide fragment corresponding to amino acids 358-374 of the C terminal region of human beta-actin 5, 6. 2A3 has been used as a loading control in Western blotting 7 - 16. Antigen Distribution Beta-actin is constitutively expressed in all types of cells as the basic
building block of cytoskeletal microfilaments.
NCBI Gene Bank ID UniProt.org Research Area Cell Biology References & Citations1. Dominguez R, Holmes KC. Annu Rev Biophys. 40:169-86. 2011. 2. Li J, Dai F, Kou X, et al. Cell Mol Neurobiol. 43(2):683-696. 2023. 3. Pollard TD, Cooper JA. Science. 326(5957):1208-1212. 2009. 4. Khan SA, Tyagi M, Sharma AK, et al. World J Gastroenterol. 20(34):12202-12211. 2014. 5. Frohner IE, Mudrak I, Schüchner S, et al. Cell Rep. 30(9):3171-3182.e6. 2020. 6. Frohner IE, Mudrak I, Kronlachner S, et al. Sci Signal. Jan 28;13(616):eaax6490. 2020. 7. Kim HH, Moon OJ, Seol YH, et al. Bioeng Transl Med. 8(3):e10489. 2023. 8. Miu BA, Voinea IC, Diamandescu L, et al. Int J Mol Sci. 24(7):6401. 2023. 9. Zhang J, He M, Xie Q, et al. ACS Omega. 7(49):45023-45035. 2022. 10. Yu JE, Kim Y, Hong DE, et al. J Oncol. 2022:8916464. 2022. 11. Wang Z, Guo K, Gao P, et al. Theranostics. 11(15):7491-7506. 2021. 12. Khodarahmian M, Amidi F, Moini A, et al. J Reprod Immunol. 143:103248. 2021. 13. Mehdi S, Macdonald E, Galpin K, et al. Int J Mol Sci. 21(14):4992. 2020. 14. Ye Y, Zhang L, Song Y, et al. Mol Med Rep. 20(4):3874-3882. 2019. 15. Chen Z, He J, Xing X, et al. Oncol Lett. 16(3):3943-3948. 2018. 16. Cao J, Liu XM, Huang LL, et al. Int J Mol Med. 41(6):3115-3126. 2018. Technical ProtocolsCertificate of Analysis |
Formats Available
- -
- -
Prod No. | Description |
---|---|
A470 | |
A472 | |
A471 |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.